[HTML][HTML] Microglial NLRP3 inflammasome activation upon TLR2 and TLR5 ligation by distinct α-synuclein assemblies

H Scheiblich, L Bousset, S Schwartz… - The Journal of …, 2021 - journals.aai.org
Parkinson's disease (PD) is the second most common age-related neurodegenerative
disorder and is characterized by the formation of cellular inclusions inside neurons that are …

Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

D Trudler, KL Nazor, YS Eisele… - Proceedings of the …, 2021 - National Acad Sciences
Parkinson's disease is characterized by accumulation of α-synuclein (αSyn). Release of
oligomeric/fibrillar αSyn from damaged neurons may potentiate neuronal death in part via …

α‐Synuclein evokes NLRP3 inflammasome‐mediated IL‐1β secretion from primary human microglia

AF Pike, T Varanita, MAC Herrebout, BC Plug, J Kole… - Glia, 2021 - Wiley Online Library
Synucleinopathies such as Parkinson's disease (PD) are hallmarked by α‐synuclein (α‐syn)
pathology and neuroinflammation. This neuroinflammation involves activated microglia with …

[HTML][HTML] Targeting microglial α-synuclein/TLRs/NF-kappaB/NLRP3 inflammasome axis in Parkinson's disease

Y Li, Y Xia, S Yin, F Wan, J Hu, L Kou, Y Sun… - Frontiers in …, 2021 - frontiersin.org
According to emerging studies, the excessive activation of microglia and the subsequent
release of pro-inflammatory cytokines play important roles in the pathogenesis and …

[HTML][HTML] MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease

Y Zhou, M Lu, RH Du, C Qiao, CY Jiang… - Molecular …, 2016 - Springer
Abstract Background α-Synuclein (α-Syn), a pathological hallmark of Parkinson's disease
(PD), has been recognized to induce the production of interleukin-1β in a process that …

[HTML][HTML] Role of NLRP3 inflammasome in Parkinson's disease and therapeutic considerations

LTN Nguyen, HD Nguyen, YJ Kim… - Journal of …, 2022 - content.iospress.com
Parkinson's disease (PD) is the second most common neurodegenerative disease, with two
main pathological features: misfolded α-synuclein protein accumulation and …

Fyn kinase regulates misfolded α-synuclein uptake and NLRP3 inflammasome activation in microglia

N Panicker, S Sarkar, DS Harischandra… - Journal of Experimental …, 2019 - rupress.org
Persistent microglia-mediated neuroinflammation is a major pathophysiological contributor
to the progression of Parkinson's disease (PD), but the cell-signaling mechanisms governing …

Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease

A Gustot, JI Gallea, R Sarroukh, MS Celej… - Biochemical …, 2015 - portlandpress.com
Parkinson's disease (PD) is an age-related movement disorder characterized by a
progressive degeneration of dopaminergic neurons in the midbrain. Although the presence …

[HTML][HTML] Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson's disease

AF Pike, F Longhena, G Faustini, JM Van Eik… - Journal of …, 2022 - Springer
Background Parkinson's disease (PD) is characterized by the loss of nigral dopaminergic
neurons leading to impaired striatal dopamine signaling, α-synuclein-(α-syn-) rich …

[HTML][HTML] Effects of innate immune receptor stimulation on extracellular α-synuclein uptake and degradation by brain resident cells

C Kim, S Kwon, M Iba, B Spencer… - … & Molecular Medicine, 2021 - nature.com
Synucleinopathies are age-related neurological disorders characterized by the progressive
deposition of α-synuclein (α-syn) aggregates and include Parkinson's disease (PD) and …